Top Markets
#1 DogBull DogBull +105.79%
#2 ADO Protocol ADO Protocol +50.39%
#3 Siacoin Siacoin +46.43%
#4 MarsCoin MarsCoin +38.80%
#5 The Bitcoin Bull The Bitcoin Bull +37.59%
#6 Glidr Glidr +24.49%
#7 Ontology Gas Ontology Gas +24.38%
#8 UnifAI Network UnifAI Network +21.47%
#9 Useless Coin Useless Coin +19.16%
#10 Falcon Finance Falcon Finance +17.48%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
ShanXi C&Y Pharmaceutical Group Co., Ltd. ShanXi C&Y Pharmaceutical Group Co., Ltd.

ShanXi C&Y Pharmaceutical Group Co., Ltd.

300254
Rank in Stocks #15734
ShanXi C&Y Pharmaceutical Group Co., Ltd. is a global pharmaceutical enterprise... ShanXi C&Y Pharmaceutical Group Co., Ltd. is a global pharmaceutical enterprise dedicated to the research, development, production, and distribution of a diverse range of medicines. Its operations span key markets including China, the United States, and Hong Kong, alongside other international regions. The company's extensive product catalog features specialized solutions for maternal and infant care, urological health, and infectious diseases, as well as traditional Chinese remedies and dermatological treatments. Additionally, it diversifies its offerings with tea bag products. Founded in 2005, the organization underwent a name change in September 2014, evolving from Shanxi C&Y Pharmaceutical Co., Ltd. to its current designation. ShanXi C&Y Pharmaceutical Group Co., Ltd. maintains its corporate headquarters in Shanghai, China.
Share Price
$1.30
Market Cap
$333.97M
Change (1 day)
0.45%
Change (1 year)
-19.21%
Country
CN
Trade ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254)

Category

Healthcare
Revenue for ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254)
Revenue in Sep 2026 TTM: 0
According to ShanXi C&Y Pharmaceutical Group Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for ShanXi C&Y Pharmaceutical Group Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH